Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas
- Conditions
- Pituitary Macroadenoma
- Interventions
- Other: intra-operative MRIProcedure: Transsphenoidal resection of pituitary macroadenoma
- Registration Number
- NCT02396810
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Brief Summary
The investigators are studying the utility of intra-operative magnetic resonance imaging (iMRI) during transsphenoidal pituitary surgery for large macroadenomas by randomizing patients to either an intra-operative MRI after resection, or no intra-operative MRI. The investigators will then count the number of gross total resection in each group of patients and also the complications related to surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 10
-
Adults 18-90
-
Capable of giving informed consent
-
Elect for transsphenoidal surgery
-
Has pre-operative MRI demonstrating pituitary tumor that is:
- deemed resectable using a transsphenoidal approach and
- has a maximal diameter equal to or greater than 15 mm.
-
No contraindications for MRI.
- Children (age < 18)
- Not able to give consent
- No pituitary tumor visible on MRI or an adenoma measuring less than 15mm in maximal dimension.
- Unable to tolerate MRI
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description intra-operative MRI Transsphenoidal resection of pituitary macroadenoma Patients undergo transspheonidal surgery followed by intra-operative MRI. No intra-operative MRI Transsphenoidal resection of pituitary macroadenoma Patients undergo transsphenoidal surgery without an intra-operative MRI. intra-operative MRI intra-operative MRI Patients undergo transspheonidal surgery followed by intra-operative MRI.
- Primary Outcome Measures
Name Time Method Rate of gross total or maximal resection 24 hours after surgery Determine whether use of iMRI in transsphenoidal pituitary surgery for pituitary macroadenomas significantly increases the rate of maximal resection
- Secondary Outcome Measures
Name Time Method Rate of Readmission 30 days post surgery Frequency of readmission
Length of anesthesia time intraoperative Length of time participant is under anesthesia
Rate of post-operative endocrinopathies 30 days post surgery Rate of post-operative endocrinopathies
Frequency of post-operative CSF leak 30 days post surgery Frequency of post-operative Cerebrospinal Fluid (CSF) leak
Operative time intraoperative Length of operation
Trial Locations
- Locations (1)
Dartmouth Hitchcock Medical Center
🇺🇸Lebanon, New Hampshire, United States